文献速递神经外周血管介入USDSA

药物洗脱球囊治疗颈动脉支架置入术后复发性狭窄:单中心回顾性分析

Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis.
PubMed 文献 · Neuroradiology · 2017-10-20

该单中心回顾性分析纳入2009至2015年间176例颈动脉支架置入患者,用双功能超声检出9例重度支架内再狭窄,均以药物洗脱球囊治疗以预防复发性新生内膜增生,共行11次药物洗脱球囊操作。首次药物洗脱球囊治疗距初次颈动脉支架置入的中位时间间隔为9个月,围介入期未见TIA、卒中或死亡,1年无事件生存率为100%,2年、3年、5年无事件生存率均为83%。作者认为药物洗脱球囊介入似乎是对支架保护下颈动脉血管成形术后重度支架内再狭窄有效且安全的治疗。

要点

  • 双功能超声检出9例重度颈动脉支架内再狭窄,共行11次药物洗脱球囊操作。
  • 首次药物洗脱球囊治疗距初次颈动脉支架置入的中位时间间隔为9个月。
  • 围介入期未见TIA、卒中或死亡,1年无事件生存率100%,2年、3年、5年均为83%。

核心结论

  • 作者认为药物洗脱球囊介入似乎是对支架保护下颈动脉血管成形术后重度支架内再狭窄有效且安全的治疗。

研究设计与样本

  • 单中心回顾性分析,纳入2009至2015年间176例颈动脉支架置入患者,以双功能超声检出支架内再狭窄。

关键影像表现/征象

  • 双功能超声检出9例重度颈动脉支架内再狭窄,其中1例为双侧颈动脉病变伴双侧支架内再狭窄。
  • 1例在首次药物洗脱球囊介入后19个月需重复药物洗脱球囊治疗,故共行11次药物洗脱球囊操作。
  • 11次介入中3次药物洗脱球囊治疗辅以额外支架,1次需重复药物洗脱球囊治疗,3次药物洗脱球囊治疗后置入二次支架。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Early in-stent restenosis after stent-protected angioplasty of the carotid artery (SPAC) is an infrequent, but potentially harmful condition for patients with carotid artery disease.

METHODS: In our retrospective single-center analysis of 176 patients with carotid artery stenting between 2009 and 2015, using duplex ultrasound, we detected 9 patients with high-grade carotid artery in-stent restenosis. All restenosis patients were treated with a drug-eluting balloon (DEB) to prevent recurrent neointimal hyperplasia. One patient had bilateral carotid artery disease with bilateral in-stent restenosis, and 1 patient needed repeated DEB treatment 19 months after the first DEB intervention, so 11 DEB procedures, in total, were performed.

RESULTS: The median time-interval between primary carotid artery stenting and first DEB-treatment was 9 months. In 3 of the 11 interventions, the DEB treatment was assisted by an additional stent. One repeat DEB treatment was necessary, and three DEB treatments were followed by a secondary stent. No peri-interventional complications (TIA, stroke, or death) were observed during or after DEB intervention. Therefore, in the entire group, the 1y event-free survival (EFS) was 100%, and the 2y/3y/5y EFS was 83%.

CONCLUSION: DEB intervention seems to be an effective and safe treatment for patients with high-grade in-stent restenosis after SPAC.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Pohlmann C, Höltje J, Zeile M, et al. Recurrent stenosis following carotid artery stenting treated with a drug-eluting balloon: a single-center retrospective analysis. Neuroradiology. 2017. PMID: 29058047. doi:10.1007/s00234-017-1935-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。